Table 7 Distribution of values for both green and red channels obtained from CLSM and Leica LASX software analysis. These values confirmed biofilm disruption. The biofilm volume percentage for the control was higher than that of the treated biofilms, indicting biofilm disruption by the phages
From: Genomic analyses of two novel biofilm-degrading methicillin-resistant Staphylococcus aureus phages
Statistics | Volume Percent [%] | Volume [μm3] | Intensity Sum | Intensity Mean | Intensity Standard Deviation |
|---|---|---|---|---|---|
MRSAt127/4 (control) | |||||
 Trial (1) | 40.67 | 629,162.26 | 6,964,491,492 | 116.63 | 52.39 |
 Trial (2) | 92.18 | 1,303,588.41 | 10,599,441,732 | 85.66 | 61.65 |
 Trial (3) | 98.94 | 1,300,775.17 | 5,824,474,595 | 47.17 | 48.10 |
MRSA t127/4 treated with UPMK_1 for 6 h | |||||
 Trial (1) | 4.72 | 152,555.31 | 1,910,159,851 | 131.92 | 53.22 |
 Trial (2) | 7.18 | 148,423.93 | 2,142,157,850 | 152.06 | 43.82 |
 Trial (3) | 11.18 | 132,164.16 | 1,793,990,059 | 143.01 | 46.24 |
MRSAt223/20 (control) | |||||
 Trial (1) | 29.96 | 629,075.11 | 5,126,536,159 | 85.86 | 32.23 |
 Trial (2) | 21.85 | 333,184.01 | 4,568,795,881 | 144.47 | 60.08 |
 Trial (3) | 23.70 | 222,606.61 | 2,746,429,683 | 129.99 | 44.63 |
MRSA t223/20 treated with UPMK_2 for 8 h | |||||
 Trial (1) | 9.13 | 277,600.54 | 3,511,210,967 | 133.26 | 45.45 |
 Trial (2) | 8.26 | 429,907.84 | 6,218,234,982 | 152.39 | 61.49 |
 Trial (3) | 9.13 | 115,041.66 | 1,442,935,232 | 132.15 | 46.90 |